WeVote
Log In

Bill

Bill

HB 3323

Reestablishes prostate cancer programs

2026 Regular Session Introduced by Marlon Anderson

Missouri bill reestablishes prostate cancer screening and education programs to improve early detection and treatment access, particularly for high-risk populations.

Referred: Emerging Issues(H)
#healthandseniorservices #departmentof #healthcare
0
WeVote Research Nonpartisan
Bill Summary · HB 3323

Legislative bill overview

HB 3323 reestablishes prostate cancer screening, education, and treatment programs in Missouri that had previously been discontinued or defunded. The bill allocates resources to increase awareness, early detection, and access to care for prostate cancer, particularly targeting at-risk populations.

Why is this important

Prostate cancer is the second-leading cancer death among American men, with African American men experiencing significantly higher incidence and mortality rates. Reestablishing dedicated state programs can improve early detection outcomes, reduce treatment disparities, and potentially decrease mortality rates through targeted education and screening initiatives.

Potential points of contention

  • Funding source and amount: The bill's fiscal impact and whether the state has budgetary capacity to fund these programs without cutting other services
  • Screening methodology debates: Medical organizations have differing recommendations on prostate-specific antigen (PSA) screening; some emphasize shared decision-making rather than routine screening
  • Equity vs. universal approach: Questions about whether programs should focus narrowly on high-risk populations or be universally available, and whether this creates equitable or tiered access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.